Protected: Survey Answers -

An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind^{9, 10}

Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)¹¹

The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body^{2, 9, 12}

Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy¹³

Imvaggis is very well tolerated¹¹

Oestrogel (estradiol) is an oestrogen-only treatment indicated for:¹⁵

Oestrogel

Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women⁹

Oestrogel (estradiol) is an oestrogen-only treatment indicated for:15

Oestrogel

Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women9

Oestrogel (estradiol) is an oestrogen-only treatment indicated for:¹⁵

Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women⁹